Similar Papers

Paper Title
Journal
Date
Author
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Plasma D-dimer and interleukin-6 are associated with treatment response and progression-free survival in advanced NSCLC patients on anti-PD-1 therapy.
Chong Chen ... Yu Zhang
Cancer Medicine | VOL. 12
Chong Chen, et. al.Chong Chen ... Yu Zhang
16 Jun 2023
Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block.
Kimberley Hockenhull ... Raffaele Califano
Translational lung cancer research | VOL. 10
Kimberley Hockenhull, et. al.Kimberley Hockenhull ... Raffaele Califano
01 Sep 2021
Abstract 3300: Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors
Dan Zhao ... Erminia Massarelli
Cancer Research | VOL. 80
Dan Zhao, et. al.Dan Zhao ... Erminia Massarelli
13 Aug 2020
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
What’s in a name? Memory NK cells for cancer immunotherapy
Sean J Judge ... Robert J Canter
Journal for ImmunoTherapy of Cancer | VOL. 13
Sean J Judge, et. al.Sean J Judge ... Robert J Canter
31 Jan 2025
Arginase-1-specific T cells target and modulate tumor-associated macrophages
Evelina Martinenaite ... Mads Hald Andersen
Journal for ImmunoTherapy of Cancer | VOL. 13
Evelina Martinenaite, et. al.Evelina Martinenaite ... Mads Hald Andersen
29 Jan 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
Binod Dhakal ... Daniel H Fowler
Journal for ImmunoTherapy of Cancer | VOL. 13
Binod Dhakal, et. al.Binod Dhakal ... Daniel H Fowler
28 Jan 2025
Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity
Yusuke Ito ... Yuki Kagoya
Journal for ImmunoTherapy of Cancer | VOL. 13
Yusuke Ito, et. al.Yusuke Ito ... Yuki Kagoya
26 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.